Company news
Envoy Medical, Inc. news in 2025
Envoy Medical, Inc.'s news releases, calls and decks from 2025, newest first.
Envoy Medical Reaches Enrollment Milestone in Pivotal Clinical Study of Fully Implanted Acclaim(R) Cochlear Implant
December 18, 2025
Envoy Medical Secures New Australian Patent for Cochlear Implant Innovation Aimed at Enhancing Input Signal-to-Noise Ratio
December 16, 2025
Envoy Medical Completes First Set of Activations in Final Stage of Pivotal Clinical Study for its First-Of-Its-Kind Fully Implanted Acclaim(R) Cochlear Implant
December 10, 2025
Envoy Medical to Host Fireside Chat with CEO Brent Lucas and the First Acclaim(R) Cochlear Implant Patient
December 4, 2025
Envoy Medical Announces the Grant of Its 40th U.S. Patent
December 2, 2025
Envoy Medical Secures New U.S. Patent for Innovative Cochlear Implant System Featuring a Removable Earplug Sensor and an Implanted Battery
November 20, 2025
Envoy Medical Achieves Six-Month Milestone with First 10 Patients in Acclaim(R) Cochlear Implant Clinical Trial
November 18, 2025
Envoy Medical Reports Third Quarter 2025 Financial and Operational Results
November 10, 2025
Envoy Medical Announces First Three Patients Enrolled in Final Stage of Acclaim(R) Cochlear Implant Pivotal Clinical Trial
November 4, 2025
Envoy Medical Marks Three-Year Anniversary of First Patient Receiving Its Breakthrough Fully Implanted Cochlear Implant
October 29, 2025
Envoy Medical Receives Positive Listing Determination from NASDAQ
October 27, 2025
Envoy Medical to Present at the Virtual Technology Investor Conference on October 28th
October 23, 2025
Envoy Medical Announces Closing of Up to $16 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
October 9, 2025
Envoy Medical Announces up to $16 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
October 8, 2025
Envoy Medical Receives FDA Approval to Expand Its Pivotal Clinical Trial to Final Stage Based on Submission of Promising Three-Month Data
October 7, 2025
Envoy Medical to Participate in the American Academy of Otolaryngology Head and Neck Surgery (AAO-HNSF) Conference on October 11th-14th
October 1, 2025
Envoy Medical Announces Closing of $2.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
September 25, 2025
Envoy Medical Advances Commercialization Planning for Breakthrough Hearing Device as FDA Clinical Trial Remains On Track
September 24, 2025
Envoy Medical Announces $2.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
September 22, 2025
Envoy Medical Expands Patent Portfolio by Securing Additional European Patent for Breakthrough Cochlear Implant Technology
September 19, 2025
Envoy Medical Issues Letter to Shareholders and Provides Update on Recent Accomplishments
September 10, 2025
Envoy Medical Secures Four New Global Patents, Expanding Its Leadership Position in Fully Implantable Hearing Technology
September 9, 2025
Envoy Medical to Present at the H.C. Wainwright 27th Annual Global Investment Conference on September 8-10, 2025
September 8, 2025
Envoy Medical Successfully Reaches Three-Month Follow-Up Milestone in Clinical Trial of the Acclaim Fully Implanted Cochlear Implant
September 3, 2025
Envoy Medical Extinguishes over $32 Million in Debt, Strengthening Balance Sheet; Announces Retirement of Glen A. Taylor from Board
August 26, 2025
Envoy Medical Secures Three New Patents, Strengthening Leadership in Fully Implantable Hearing Technology
August 20, 2025
Envoy Medical Reports on Second Quarter 2025 Results
July 31, 2025
Envoy Medical Expands Patent Portfolio with New Issuances in the United States
July 8, 2025
Envoy Medical Expands Global Patent Portfolio with New Issuances in Australia
July 1, 2025
New CPT Codes for Totally Implantable Active Middle Ear Hearing Implants Go into Effect July 1, Unlocking New Opportunities for Envoy Medical
June 26, 2025
Envoy Medical to Present at the Life Sciences Virtual Investor Forum June 12th
June 11, 2025
Envoy Medical's Pivotal Clinical Trial for Fully Implanted Acclaim(R) Cochlear Implant Remains On Track After First Month Follow-Up
June 10, 2025
Envoy Medical Achieves Clinical Trial Milestone and is Optimistic About Expansion into Final Stage of Trial
May 13, 2025
Envoy Medical Reports on First Quarter 2025 Results
May 1, 2025
Envoy Medical Reports Fourth Quarter and Full Year 2024 Financial Results
March 31, 2025
Hearing Device Coverage Clarification Act Reintroduced in House and Senate
March 17, 2025
Envoy Medical Secures $10 Million in Funding to Advance Pivotal Clinical Trial of Breakthrough Hearing Device
March 12, 2025
Envoy Medical to Participate in the 37th Annual ROTH Conference
March 10, 2025
First Two Participants Successfully Enrolled In Pivotal Clinical Study For Breakthrough Fully Implanted Cochlear Implant
February 24, 2025
Envoy Medical Secures Additional Patent Protection for Its Growing Patent Portfolio
February 13, 2025
Decks in 2025
- Investor Presentation (December 2025)
Investor deck · 31 slides · Dec 16, 2025